Ministry of Pharmaceutical Industry National Agency of Pharmaceutical Products

Note No. 49-2026 on the suspension of the pharmaceutical product quality control service

Note to establishments 49-2026

Note to pharmaceutical establishments temporarily suspending the pharmaceutical product quality control service provided by the Agency's laboratories.

Documents

note-n49-2026-relative-a-la-suspension-de-la-prestation-de-service-de-controle-de-qualite-des-produits-pharmaceutiques.pdf (140.6 KB)

Record updated on 26 August 2026

Back to regulations

12 health alerts in progress Batch recall - GANT H gloves All alerts